The poster boards are in landscape format, approximately 6 feet (194 cm) wide by 3 feet (95 cm) high. Posters will be mounted using a special two-sided adhesive tape. Posters must be set up between 0730 and 0800 daily on the day of your presentation, and must be taken down by 1600 that day. ISPE will not be responsible for any poster that is left up overnight and is lost or damaged.

Poster sessions will be moderated. Presenters should be at their poster from 1200 to 1400. There will be a daily judging for the best poster presentations. The first prize poster winners will be invited to keep their posters up through the end of the meeting. The best overall poster presented at the 16th ICPE will be recognized and the author will receive a special award at the Closing Session on August 23.

Numbering system
The poster number is the first number listed. This is the poster on which presenters should mount their material. The abstract number, for use in locating abstracts in the special issue of Pharmacoepidemiology and Drug Safety that will be distributed at the ICPE, is in brackets [ ] after the title of the paper.

1. Attention Deficit and Hyperactivity Disorder ¿Undertreated or Underdiagnosed Children in Argentina? [4] Ricardo Bolaños, Estela R Giménez, Viglione Ariadna, Carlos Chiale, Claudio D González, Inés Bignone, Luis E Nudelman, Lilian E Caballero, Andrea Giménez, Jimena Worcel, Natalia Álvarez, Margarita Melgarejo, Raúl Plager (Argentina)
2. Patterns of Analgesic Drugs Utilisation during the Postoperative Period in a Spanish Hospital [5] E Soler Company, MT Faus Soler, MC Montaner Abasolo, F Morales Olivas, A Cuenca Soria, I Perez Castello (Spain)
3. Therapeutic Profile of Antihypertensive Drug Use by Portuguese Sentinel GP [8] Jose C Domingues, Isabel M Falcao, Paulo Goucha, Paula Martins, Magda N Melo, Zilda Mendes, Ana C Miranda (Portugal)
4. Changes in the Prescription of Oral Antihistaminergic Drugs after Changes in Reimbursement Policy in the Netherlands [11] Marcel L Bouvy, Toine C Egberts (The Netherlands)
5. Drugs in Children: Poorly Researched but Widely Used [12] Eric Schirm, Paul Van den Berg, Henkjan Gebben, Pieter Sauer, Lolkje De Jong - van den Berg (The Netherlands)
6. Estimation of Tuberculosis in Spain through the Consumption of Drugs 1993-1998 [15] Antonio Blazquez, Myriam Beaulieu, Ramona Mateos (Spain)
7. Psychopharmacology and General Practise. A Quality Improvement Project in the County of Roskilde, Denmark [16] Kirsten Schæfer, Jens J Damsgaard (Denmark)
8. Trends in Ace Inhibitor Prescribing in General Practice (1993 - 1997): An Investigation Using the General Practice Research Database [18] Heath F Heatlie, Jeff Norwood, James Bashford (United Kingdom)
9. Use of Alternative/Complementary Medicine among Managed Care Enrollees with Osteoarthritis [24] Terry S Field, Leslie Harrold, Cindy Cadoret, Marie Granlund, Jerry Gurwitz, Robert Yood, Barbara Lewis, Walter Straus (United States)
10. Drug Utilization Review of Anti-Hypertensives in Korean Elderly [32] Byung-Joo Park, Hye-Won Koo, Jong-Myon Bae (Korea)
11. Increasing Prescription Rate of Lipid Lowering Drugs after Introduction of Guidelines on Cardiovascular Risk [35] Lars Bjerrum, John Larsen, Jakob Kragstrup (Denmark)
12. An Evaluation of Drug Use in the Municipal Health Care Service of Campo Grande-MS [42] Maria Candia Nunes da Cunha, Lia Lusitana Cardozo de Castro (Brazil)
13. Exposure to Non-cardiac QT-prolonging Drugs in the Community: Comparison among Seven Countries [43] Fabrizio De Ponti, Elisabetta Poluzzi, Alberto Vaccheri, Ulf Bergman, Lars Bjerrum, John Ferguson, Peter McManus, Emilio nz, Ingrid Schubert, Gisbert Selke, Nicola Montanaro (Italy, Sweden, Denmark, United Kingdom, Australia, Spain, Germany)
14. Prevalence of Arterial Hypertension and Prescription Patterns of Antihypertensive Medication in a Primary Care Setting in an Urban Area of Germany [48] Ulrike E Vossieck-Ostertun, Jutta K Krappweis, Wilhelm Kirch (Germany)
15. Epidemiologic and Antibiogram Study of Cholera in 112 Patients with Positive Stool Cultures in Tehran, Iran [50] Hossein Sarmadian, Mehdi Mirsaidi, Anick Berard (Iran, United States)
16. Use of Antiinfectives for Systemic Use in Two Norwegian and One Croatian Hospital in 1997 and 1999 [52]Vera V Palcevski, Brita Fosse, Hege S Blix (Croatia, Norway)
17. Assessment of Indicators for Hospital Drug formulary Non-adherence [55] R Fijn, AW Lenderink, ACG Egberts, JRBJ Brouwers, LTW de Jong-van den Berg (The Netherlands)
18. The Influence of Facility Organizational Characteristics on Antipsychotic Use in US Nursing Homes [62] Carmel M Hughes, Kate L Lapane, Vince Mor (United Kingdom, United States)
19. Proposal of a Model for Analysis of the Utilization of Benzodiazepines Based on the Imports of These Drugs in the Period 1986-1997 in Argentina [65] Ricardo Bolaños, Estela R Giménez, Ariadna Viglione, Carlos Chiale, Inés Bignone, Claudio González, Luis E Nudelman, Caballero Liliana, Andrea Giménez, Jimena Worcel, Natalia Álvarez (Argentina)
20. Use of Systemic Anti-infectives in Iran during 1997-1998 [72] Faranak Ansari (Iran)
21. Use of Psychotropics in Iran during 1997-1998 [76] Faranak Ansari (Iran)
22. Individual Use of Antibiotics and Prevalence of Beta-lactam Resistance among Bacterial Pathogens from Middle Ear Fluid [80] Nana Thrane, Charlotte Olesen, Henrik T Sørensen, Henrik C Schønheyder (Denmark)
23. Long Term Therapy with Spironolactone Might be Difficult To Achieve [82] Marcel L Bouvy, Eibert R Heerdink, Ron MC Herings, Hubert G Leufkens (The Netherlands)
24. Trends in the Use of Antiasthmatics in Spain [85] Vitorina Garcia del Pozo, Javier Garcia del Pozo, Antonio Blazquez, Alfonso Carvajal, Ramona Mateos (Spain)
25. Comparison of Anti-asthmatic Drugs Consumption among Five European Countries [86] Francesco Bamfi, Paolo Rizzini, Davide Festi, Tommaso Staniscia, Ferdinando Romano (Italy)
26. The Treatment of Bell's Palsy in General Practice [89] Sam Rowlands, Richard AC Hughes, Peter Burney, Richard Hooper (United Kingdom)
27. Use of Antidepressants from 1992 to 1997 with Focus on Duration of Treatment and Age-Related Prevalence (County of Funen, 470 000 Inhabitants) a Prescription Database Study [90] Jens-Ulrik Rosholm, Morten Andersen, Lars F Gram (Denmark)
28. Inappropriate Prescriptions for the Aging Population of the United States: An Analysis of the National Ambulatory Medical re Survey, 1977 [92] Boji Huang, Kenneth A Bachmann, Vilma T Falck, Xuming He, Randi Chen, Jennifer L. McAllister (United States)
29. Academic Detailing for Better Use of Prostate Specific Antigen (PSA) Testing [98] David Weller, Debra Rowett, Louise Quinn, Carole Pinnock, Adrian Esterman, Frank May (United Kingdom, Australia)
30. Prescribing Patterns of Methylphenidate in a South African Patient Population [114] Ilse Truter, Theunis J van W Kotze (South Africa)
31. Prescribing of Tricyclic Antidepressant Drugs in South Africa with Emphasis on the PDD Methodology [121] Ilse Truter, Theunis J van W Kotze (South Africa)
32. Prescribing Patterns of Sumatriptan in a South African Patient Setting [122] Ilse Truter (South Africa)
33. Aberdeen-Southampton-Keele (ASK) 'over-the-Counter' Medicines Study [124] Deborah Layton, Nicholas R Dunn, ad A Shakir (United Kingdom)
34. Antibiotics Utilization and the Cultural Context: An Anthropological Investigation of the Lay Perspective in a Dutch and a Belgian City [130] Reginald Deschepper, Robert Vander Stichele (Belgium)
35. Effectiveness of Antibiotic Prescribing and Patient Outcomes in a Community Setting [139] Justin J Beilby, John E Marley, Don C Walker, Nicole L Chamberlain, Katherine M Duszynski (Australia)
36. Drug Therapy for Patients Diagnosed with Menopausal Symptoms in South Africa [141] Ilse Truter (South Africa)
37. The Use of Anti-asthmatics among Danish Children in 1998 [149] Bente Krag Ingvardsen, Janne Malene Kampmann, lle Landberger Johansen (Denmark)
38. Regional Differences in the Use of Antibiotics among Danish Children in 1998 [151] Helle Landberger Johansen, Janne Malene Kampmann, Bente Krag Ingvardsen (Denmark)
39. A Study of Antibiotic Resistance in Women Treated for Urinary Tract Infections [153] John W Logie, Ross A Lawrenson (United Kingdom)
40. Organization of a Data Collection Circuit on Drug Dispensing from 924 Community Pharmacies in France [162] J Gallezot, G Bauguil, E Van Ganse, T Vial, G Chamba (France)
41. Clinical Pharmacists' Interventions: A Report from 924 Community Pharmacies in France [164] G Bauguil, J Gallezot, E Van Ganse, T Vial, G Chamba (France)
42. A Comprehensive Ongoing Population-Based Survey of Medication Use in the United States: The Adult Population [165] DW Kaufman, JP Kelly, TE Anderson, L Rosenberg, AA Mitchell (United States)
43. Estrogen Replacement Therapy: Determinants of Persistence with Treatment [167] Danielle Pilon, Anne-Marie Castilloux, Jacques LeLorier (Canada)
44. Inappropriate Medication Prescribing during the Transition from Ambulatory to Long Term Care Facility Setting [172] Jyotsna Dhall, Kate Lapane, E. Paul Larrat (United States)
45. Persistence on Acetaminophen and Classical NSAID in Elderly Patients [180] Anne-Marie Castilloux, Dan Pettitt, Jacques LeLorier (Canada, United States)
46. Helicobacter pylori Eradication: Drug Utisation Review [191] Odile Sheehy, Jacques LeLorier (Canada)
47. Folic Acid - and Iodide-Prophylaxis in Pregnancy in Germany - Results from the PEGASUS-Project [199] Veronika en, Joerg Hasford (Germany)
48. Patterns of Prescribing of Ace Inhibitors in Primary and Secondary Care in Greater Glasgow [200] Audrey Thompson, Paul Davies, Keith Beard (United Kingdom)
49. Respiratory Symptoms, Clinical Diagnosys and Prescribing Characteristics in a Population-Based Study of Chronic Obstructive Pulmonary Disease in Udine, Italy [205] Guglielmo Pitzalis, Tiziana Lombardelli, Valentina Brussi, Paolo Monte, Andrea Giacomelli, Fabio Barbone (Italy, United States)
50. Determinants of Non-Compliance with the Lipid Lowering Therapy in Korean Subjects [216] Young-Sik Kim, Hye-Ree Lee, Keun-Mi Lee, Sang-Wook Song, Yong-Woo Park, Ho-Cheol Shin, Cheol-Hwan Kim, Dae-Hyeun Kim, Byung-Sung Kim, Hyeong-Soo Cha, Bong-Yul Huh (Korea)
51. Consumption of Antihypertensive Agents in Hungary (1991-1998) [220] Zsuzsa Szepezdi, Laszlo Gyorgy, Eva Csekey, Tamas L Paal (Hungary)
52. Private Practitioners' Anti-Microbial Prescription Patterns for Acute Respiratory Infections in Children [228] Youngsung Lee, Kun-Sei Lee (Korea)
53. Antibacterial Drug Use and Anti-Microbial Resistance in Vilnius University Hospital in 1997 and 1999 [230] Jolanta Gulbinovic, Ruta Petruskeviciene, Janina Bytautiene (Lithuania)
54. A Tool Useful for Pharmacoepidemiology: The "TAXE" Database. Example of Use in Asthma [233] Emmanuel Guin, Philippe Cavalie, Alain Rauss (France)
55. Utilisation of Lipid Lowering Drugs Correlated to Serum Cholesterol Values among People with Myocardial Infarction 1994-1997 in Odense, Funen County, Denmark [234] John Larsen, Morten Andersen, Lars Bjerrum, Jakob Kragstrup, Lars F Gram (Denmark)
56. Peripheral Vasodilators Prescriptions. A Study Conducted in Two French Social Security Regimes (CANAM and MSA) [237] Isabelle Castano, Benoît Crochet, Jean Deligne, Michèle Rey, Pascale Zagury, Philippe Maugendre, Alain Rauss (France)
57. Drug Utilisation in Children: A Population-Based Study [238] Corinne S de Vries, Steve A Greene, Ian A Hunter, Andrew D Morris (United Kingdom)
58. The Therapeutic Course as a Measure of Exposure to Antibiotics Alternative to DDD [240] Davide Resi, Cristina Castelvetri, Alberto Vaccheri, Nicola Montanaro (Italy)
59. Drug Consumption in Norway 1999 - Key Figures and Trends [242] Marit Ronning, Hege Salvesen Blix, Hanne Strom, Bente Tange Harbo, Lill Fevang Harr (Norway)
60. Databased Group Auditing for Pharmacists To Improve the Counselling of Patients with Pain [243] Ingrid Schubert, Jutta Krappweis, Barbara Beekes, Hans Krappweis, Liselotte von Ferber, Wilhelm Kirch (Germany)
61. Use of Psycho-Phytopharmaceuticals in German Surveys from 1984 to 1999 - Results for Hypericum-, Valeriana- and Humulus-Drugs [256] Hans-Ulrich Melchert, Hildtraud Knopf, Ellen Pabel, Annekarin Bertelsmann (Germany)
62. The Incidence and Duration of Missed Doses during SSRI Treatment [258] Welmoed EE Meijer, Marcel Bouvy, Eibert R Heerdink, John Urquhart, Hubert GM Leufkens (The Netherlands)
63. Decision Criteria in the Treatment of Depression [261] Ger Th Werf van der, Roy Stewart, Ceciel Aarnoudse, Petra Denig, Flora M Haaijer-Ruskamp (The Netherlands)
64. Asthma and Asthma Medication - A Database Study of Asthma Treatment in General Practice [262] Lisa G Pont, Flora M Haaijer-Ruskamp (The Netherlands)
65. NSAID Use Among Outpatients at High Risk for Adverse Drug Reactions in a German Area [263] Jutta K Krappweis, Wilhelm Kirch (Germany)
66. Concomitant Prescribing of Antidepressants and Anxiolytics or Hypnotics in the Elderly [265] Karen N Van Dijk, Kirsten Ter Huurne, Paul B Van den Berg, Corinne S De Vries, Koos RBJ Brouwers, Lolkje TW De Jong-van den Berg (The Netherlands, United Kingdom)
67. Prevalence of Hormone Replacement Therapy (HRT) in Norwegian Women 45-64 Years: User Characteristics and Choices of Therapy. The Norwegian Women and Cancer Study [267] Anne Elise Eggen, Kjersti Bakken, Eiliv Lund (Norway)
68. Prescription of Ranitidine, Cimetidine and Omeprazole: A Multicenter Study [268] Francis SV Tourinho-Pereira, Gun B Bergsten-Mendes (Brazil)
69. Longitudinal Analysis of the Number of Drugs Used in the Elderly: Data from the Paquid Cohort [269] Annie Fourrier, Luc Letenneur, Jean François Dartigues, Bernard Begaud (France)
70. Health Related Behavior and Use of Hormone Replacement Therapy [273] Ilona Csizmadi, Andrea Benedetti, Jean-Paul Collet, James Hanley, Jean-Francois Boivin (Canada)
71. Impact of Restrictive Drug Reimbursement on the Quality of Care: The Case of Bisphosphonates [274] Odile Sheehy, Jean-Marc Boucher, Jacques LeLorier (Canada)
72. Can I Open the Drug Container and Swallow the Tablet? A Study of Drug Intake in the Elderly [275] Anna Beckman, Cecilia B Bernsten, Johan Fastbom (Sweden)
73. Prescription Based Study on the Use of Orlistat [278] Bjorn Beermann, Juliette Säwe, Cecilia Ulleryd, Marianne Wierup, Rune Dahlqvist (Sweden)
74. Analgesic Consumption Patterns and Their Determinants in Germany (West) from 1984-1991 [282] Chistoph Laer, Marion Schaefer, Hans-Ulrich Melchert (Germany)
75. Psychotropic Drug Use in Mentally Retarded Group Home Residents with Behavioural Problems [288] Joost J Stolker, Peter J Koedoot, Eibert R Heerdink, Hubert G Leufkens, Willem A Nolen (The Netherlands)
76. Polypharmacy Is a Real Need or an Incorrect Habit of GP in Hungary ? [289] Gyongyver Soos, Zsuzsanna Reszketo ()
77. Relevance of Interventions To Reduce Polypharmacy [290] Lisa G Pont, Jellie Meindersma, Bert Tent, Flora M Haaijer-Ruskamp (The Netherlands)
78. Determinants of Multiple Psychotropic Drug Usage in a Unit for Intellectually Disabled Patients with Challenging Behaviour [291] Joost J Stolker, Eibert R Heerdink, Hubert G Leufkens, Mariet GM Clerkx, Willem A Nolen (The Netherlands)
79. Antidepressant Drug Use in an Elderly Population: Results from the Paquid Cohort [294] Eric Pohier, Annie Fourrier, Bernard Begaud, Jean Francois Dartigues (France)
80. Assessing Patient Knowledge and Concordance in a Hypertension Clinic [295] Mary J Macleod, Sarah Wahluda, James S McLay (United Kingdom)
81. The Utilization Rate of Estrogen Replacement Therapy in Manitoba's Post-Menopausal Women: A Population-Based Analysis [301] Patricia A Caetano, Colleen J Metge (Canada)
82. NSAIDs and Colon Cancer Progression [307] Andrea Benedetti, Jean-Paul Collet, Colin Sharpe, James Hanley, Jean-Francois Boivin (Canada)
83. Patterns and Predictors of Tacrine Use [312] Minalkumar A Patel, Rhonda L Bohn, Raisa Levin, Jerry Avorn (United States)
84. Compliance with Antihypertensive Medication: Predictors of Patient Over-Reporting [313] Joshua S Benner, Philip S Wang, Matthew A Gubens, Wolfgang C Winkelmayer, Jerry Avorn (United States)
85. Utilization of Euthanatica in Belgium: Results of a Death Certificate Study [318] Robert H Vander Stichele, Luc HJ Deliens, Johan JR Bilsen, Reginald Deschepper, Freddy Mortier (Belgium)
86. The Impact of Information Guides on the Prescription of Antidepressants in the Elderly Population [328] Thierry Ducruet, Yola Moride, Guillaume Galbaud du Fort, Claudine Laurier, Johanne Monette, Jean-Francois Boivin, Nathalie Champoux, Ralph Crott (Canada)
87. Patterns of Use of Hormone Replacement Therapy in Spain [336] Ana Alvarez-Requejo, Alfonso Carvajal, Javier Garcia del Pozo, Mikhail Benet Rodriguez, Ana M Rueda de Castro (Spain)
88. Consumption and Supply of Lipid-Lowering Drugs in Spain (1986-1998) [338] Alfonso Carvajal, Javier Garcia del Pozo, Mikhail Benet Rodriguez, Luis H Martin Arias, Ana M Rueda de Castro (Spain)
89. Pattern of Drug Prescribing in Outpatient Adults with Acute Exacerbation of Chronic Bronchitis (AECB) [340] Leonid Stratchounski, Svetlana Ratchina, Sergey Kozlov, Oleg Karpov, Sergey Nedogoda, Natalya Domnikova, Rita Lihatcheva, Vladimir Kuzin, Igor Leschenko (Russia)
90. Impact of Regulatory Activity on Prescription Use of Troglitazone [357] David J Graham, Carol R Drinkard, Deborah Shatin (United States)
91. Relation between Prescribed Cardiovascular Drugs and Prescribers [360] Murilo Freitas Dias, Micheline MM de A Meiners, Leandra C Miranda, Carlos CF Vidotti (Brazil)
92. Evaluationon of Post-Operative Pain and Its Treatment [361] Jose L Castro, Fernanda Manchado, Mirta Iglesias, Adriana Frojan, Patricia Avakian, Claudio Gonzalez, Irma Arias, Antonio Vallano (Argentina)
93. Appropriateness of Drug Use in an Institutionalised Elderly Population [363] Carol Rancourt, Jocelyne Moisan, Lucie Baillargeon, Rene Verreault, Jean-Pierre Gregoire (Canada)
94. Efficacy and Tolerance of Antidepressants: What Psychiatrists Think, What Happens to Patients [366] Nicholas D Moore, Fanny Depont, Sahondra Rambelomanana, Bernard Begaud (France)
95. Drug Utilization Markers for Antidepressants Prescribing [377] Carlos De las Cuevas, Emilio J Sanz (Spain)
96. Prevalence of Potential Drug Interactions in Sweden [378] Juan Merlo, Hans Liedholm, Agneta Bjorck-Linne, Thor Lithman, Jurgen Falt, Arne Melander (Sweden)
97. A One-Year Follow-Up Study of COPD in Primary Care [380] Marc Miravitlles, Cristina Murio, Tina Guerrero (Spain)
98. Patient Demand and Physician's Prescribing [382] Liselotte von Ferber, Ingrid Koester, Ulrike Pruess, Ingrid Schubert (Germany)
99. The Implementation of Pharmacotherapeutic Guidelines for General Practitioners: "Blind Spots, Cognitive Deficits, Emotional Resistance to Learning" [383] Liselotte von Ferber, Ingrid Schubert, Peter Ihle, Christian von Ferber (Germany)
100. Analysis of Drug Dispensation and Expenditure in the District of Varese, in Northern Italy [387] Olivia Leoni, Marco Cosentino, Donatella Michielotto, Fabio Banfi, Sergio Lecchini, Gianmario Frigo (Italy)
101. Comparison of Pediatric Prescription Pattern in Different Countries (Spain, Bulgaria, Russia, Slovak and Czech Rep): Some Room for Improvement [388] Emilio J Sanz, Miguel A Hernández, Momtcheva-Ivanova Hristina, Rachina Sveta, Peire Asunción, Martínez Inocencia, Krajnakova Hana, Seifertova J (Spain, Bulgaria, Russia, Spain, Slovakia, Czech Republic)
102. Quantifying the Impact of Interactions between HMG-CoA Reductase Inhibitors and Cytochrome P-450 Interacting Drugs on Healthcare Utilization: A Population-Based Study [393] Colleen J Metge, Michael Iskedjian, Thomas R Einarson, Marina Yogendran, Jayanti Mukherjee (Canada)
103. Gender Differences in Patient Reported Drug Utilization Patterns of HIV Infected Outpatients in Ontario, Canada - An Interim Assessment [394] Michelle D Furler, Sharon Walmsley, Thomas R Einarson, Reina Bendayan (Canada)
104. Tolerability of Miglitol in the Treatment of Type 2 Diabetes Mellitus. Preliminary Data after 3 Months of Follow-up [396] M Puig-Domingo, P Benito, E Faure, R García-Mayor, J Mesa, LF Pallardo, JS López, R Ravella (Spain)
105. Patients Perceptions of Antidepressant Treatment. An Anthropological Qualitative Approach [397] Emilio J Sanz, Vinita Mahtani (Spain)
106. Patient Reported Complementary and Alternative Medicine (CAM) Use in Ontario HIV Outpatient Clinics - an Interim Assessment [399] Michelle D Furler, Sharon Walmsley, Thomas R Einarson, Reina Bendayan (Canada)
107. NSAID Prescribing by General Practitioners in Denmark (Funen), Italy (Ravenna Area) and Sweden (Stockholm) [402] Ulf Bergman, Alberto Vaccheri, Lars Bjerrum, Björn Werttermark, Peter Engfeldt, Nicola Montanaro (Sweden, Italy, Denmark, Sweden)
108. The Status of Medical Prescriptions for Children between 0 to 2 Years of Age That Attended Americo Brasilenses' Municipal Health Centers, SP - Brazil [405] Maria Jacira Simoes, Rosa Carneiro Carneiro, Maria Cristina Marques (Brazil)
109. Drug Use in Early Pregnancy - The Impact of Maternal Health and Socio-Demographic Factors [232] Hedvig Nordeng, Anne Eskild, Britt-Ingjerd Nesheim, Geir Jacobsen (Norway)

1. Comparison of Different Methods To Estimate Prevalence of Drug Use by Using Pharmacy Records [2] Aukje K Teeuwisse, Olaf H Klungel, WM Monique Verschuren, Arijan Porsius, Anthonius de Boer (The Netherlands)
2. Quality of Life in Hypertension: How Valid Is the SF-12? [17] Isabelle IC Côté, Jean-Pierre JPG Grégoire, Jocelyne JM Moisan, Isabelle IC Chabot (Canada)
3. Anaphylactoid Reactions to Contrast Media: What Is the Role of Cardiac Comedication? [22] Alexander Michel, Abudulai Alhassan, Hans J Maurer, Wolfgang Schumann (Germany)
4. Cardiovascular Morbidity Precedes Oral Antidiabetic Treatment in Patients with Diabetes Mellitus Type 2 [27] Joelle A Erkens, Ron MC Herings, Ronald P Stolk, Jose A Spoelstra, Diederick E Grobbee, Hubert GM Leufkens (The Netherlands)
5. Are Schizophrenia or Antipshychotic Drugs a Risk Factor for Cataracts? [30] Ana Ruigomez, Luis Alberto Garcia Rodriguez, Vikram J Dev, Felix Arellano, Joher Raniwala (Spain, United States, United Kingdom)
6. Start of a Selective Serotonin Reuptake Inhibitor (SSRI) and Increase of Antiparkinsonian Drug Treatment in Patients on Levodopa [31] David AMC van de Vijver, Raymund AC Roos, Paul AF Jansen, Arijan J Porsius, Anthonius de Boer (The Netherlands)
7. Gender Differences in Treatment and Mortality Among Heart Failure Patients [33] Saga Johansson, Mari-Ann Wallander, Ana Ruigomez, Luis Alberto Garcia Rodriguez (Sweden, Spain)
8. Incidence of Newly Diagnosed Heart Failure in General Practice [34] Saga Johansson, Mari-Ann Wallander, Ana Ruigomez, Luis Alberto Garcia Rodriguez (Sweden, Spain)
9. Concomitant Use of Folic Acid Prolongs Duration of MTX-Therapy in the Treatment of RA [44] Paul B van den Berg, Aarnout Reicher, Lolkje TW de Jong-van den Berg (The Netherlands)
10. Frequency of Dysthyroidism to Amiodarone: A Comparative Retrospective Study (1990-1997) in South of France [49] Bagheri-Charabiani Haleh, Lapeyre-Mestre Maryse, Levy Carole, Haramburu Francoise, Hillaire-Buys Dominique, Blayac Jean-Pierre, Montastruc Jean-Louis (France)
11. Do the Enteric-Coated Formulations of Low-Dose Aspirin Reduce the Risk of Upper Gastrointestinal Complications? [51] Francisco J De Abajo, Luis A Garcia Rodriguez (Spain)
12. Developement of a Disability Index for Rheumatoid Arthritis Using Service Utilization Variables [56] Anick Berard, Daniel H Solomon, Fred Wolfe, Robert J Glynn, Jerry Avorn (United States)
13. Diagnosis, Follow Up and Treatment of a Community-Based Incident Cohort of Patients with Hepatitis C [58] Barbara P Yawn, Peter G Wollan, Lilliana W Gazzuola, Ray W Kim (United States)
14. Sudden Sleep Attacks and Antiparkinsonian Drugs: A Pilot Pharmacoepidemiological Study [59] Jean-Louis Montastruc, Christine Brefel-Courbon, Jean-Michel Senard, Karine Desboeuf, Olivier Rascol, Maryse Lapeyre-Mestre (France)
15. Diagnosis and Management of a Community-Based Incident Cohort of People with Irritable Bowel Syndrome [60] Barbara P Yawn, Peter A Wollan, Susan T Bertram, Margary L Kurland, Giles R Locke, Eva L Lydick (United States)
16. Pregnancy Outcome Following Gestational Exposure to Venlafaxine: A Prospective Controlled Multicentre Study [64] Adrienne Einarson, Bunmi Okotore, Christina D Chambers, Pierpaolo Mastroicovo, Antonio Addis, Lavinia Schuler, Gideon Koren (Canada, United States, Italy, Brazil)
17. Evaluation of the Profile of Patients with QTc Prolongation in Spontaneous Adverse Event Reporting over the Past Three Decades - 1969 to 1998 [66] Man C Fung, Jasmanda Hsiao-hui Wu, Kenneth Kwong, Ken Hornbuckle, Edmundo Muniz (United States)
18. Aspirin Use and Early Diagnosis of Colorectal Cancer - A Population Based Study [69] Til Sturmer, Hermann Brenner (Germany)
19. Variability of Spontaneous Adverse Reactions Codification by Different Health Professionals: An Italian Study [81] Andrea Lanza, Ambrogio Bottoni, Alberto Vaccheri, Nicola Montanaro (Italy)
20. Female Hormones and Microalbuminuria [95] Taco BM Monster, Wilbert MT Janssen, Paul B van den Berg, Paul E de Jong, Lolkje TW de Jong-van den Berg (The Netherlands)
21. Thyroxine Treatment and the Risk of Hip Fracture: A Case-Control Study Using the UK General Practice Research Database (GPRD) [102] Richard Hubbard, Liam Smeeth, Chris Smith, Sam Rowlands, Hassy Devalia, Alan Dean (United Kingdom)
22. The Use of a Medical Dictionary for Regulatory Activities Terminology (MedDRA) for Signal Generation in Prescription-Event Monitoring in Japan (J-PEM) [107] Miki Yokotsuka, Misako Aoyama, Kiyoshi Kubota, Eri Kawabe, Yasuko Morita, Chikuma Hamada, Shiro Hinotsu (Japan)
23. Improving Specificity Associated with Signal Generation in Prescription-Event Monitoring in Japan (J-PEM) [110] Kiyoshi Kubota, Eri Kawabe, Chikuma Hamada, Miki Yokotsuka, Yasuko Morita, Shiro Hinotsu, Yasuo Ohashi (Japan)
24. Troglitazone and Liver Dysfunctions: Postmarketing Surveillance Study [111] Pipasha N Biswas, Lynda V Wilton, Gillian L Pearce, Shayne N Freemantle, Saad AW Shakir (United Kingdom)
25. Evaluation of the Profile of Patients with Liver Necrosis and Failure in Spontaneous Adverse Event Reporting over the Past Three Decades - 1969 to 1998 [113] Man C Fung, Jasmanda Hsiao-hui Wu, Kenneth Kwong, Ken Hornbuckle, Edmundo Muniz (United States)
26. Revisiting the Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy: A Quantitative Review [117] Sheila R Weiss, Jalpa A Doshi, Jeanne M Manson (United States)
27. Cohort Study on the Association between Anti-hypertensive Drugs and All-Cause Mortality in Korean Elderly People [119] Hye-Won Koo, Byung-Joo Park, Kui-Oak Jung, Dae-Sung Kim (Korea)
28. Safety Profile of the Cholinesterase Inhibitor Donepezil as Used To Treat Alzheimer's Disease in General Practice in England [126] Nicholas R Dunn, Gillian L Pearce, Saad A Shakir (United Kingdom)
29. Drug Utilization Study of Low Molecular Weight Heparin (LMWH) in a French University Hospital [132] Haleh Bagheri-Charabiani, Philippe Cestac, Maryse Lapeyre-Mestre, Atoussa Fouladi, Philippe Leger, Jean-Louis Montastruc, Pierre Sie (France)
30. Evaluation of the Profile of Patients with Pulmonary Hypertension in Spontaneous Adverse Event Reporting over the Past Three Decades - 1969 to 1998 [134] Man C Fung, Jasmanda Hsiao-hui Wu, Kenneth Kwong, Ken Hornbuckle, Edmundo Muniz (United States)
31. Cardiovascular Drug Use and Microalbuminuria [146] Taco BM Monster, Wilbert MT Janssen, Paul B van den Berg, Paul E de Jong, Lolkje TW de Jong-van den Berg (The Netherlands)
32. The Pharmacovigilance of Olanzapine: Results of a Post-Marketing Survellance Study on 8858 Patients in England [148] Pipasha N Biswas, Lynda V Wilton, Gillian L Pearce, Shayne N Freemantle, Saad AW Shakir (United Kingdom)
33. Defining a Clinically Important Difference in Pain Outcome Measures [158] John T Farrar, Russell K Portenoy, Jesse A Berlin, Judith Kinman, Brian L Strom (United States)
34. Monitoring the Risk of QT Prolongation and Sudden Cardiac Death in Patients Treated with Sertindole; A Post-Marketing Surveillance Study [159] Lynda V Wilton, Saad A Shakir (United Kingdom)
35. Hepatic Events Reported in Individual Prescription-Event Monitoring Studies of Nefazodone and 5 Other Antidepressant Drugs [160] Lynda V Wilton, Ann Arscott, Saad A Shakir (United Kingdom)
36. Assesment of Tramadol Abuse in Impaired Health Professionals [161] Sidney H Schnoll, Janet S Knisely, Eleanor Campbell (United States)
37. The Cost of Major Adverse Effects Associated with NSAIDs [168] Daniel H Solomon, Robert J Glynn, Rhonda Bohn, Raisa Levin, Jerry Avorn (United States)
38. Quasi-Experimental Designs in the Study of Drug Policy Changes with Low Participation [171] Sebastian Schneeweiss, Malcolm Maclure, Stephen B Soumerai, Alexander M Walker, Robert J Glynn (United States, Canada)
39. Incidence of First-Time Idiopathic Seizures in Users of Tramadol [174] Christiane Gasse, Catherine Vasilakis-Scaramozza, Laura E Derby, Hershel Jick (Germany, United States)
40. Estimating the Effect of Nonsteroidal Anti-inflammatory Drugs on Gastrointestinal Events among Patients with Arthritis in the Era of Managed Care and Availability of Over-the-Counter Medications [175] Kate L Lapane, Rebecca Toppa, Dan Pettit (United States)
41. Prospective Study of Analgesic Use in Patients with Chronic Pain [176] Edgar H Adams, James A Inciardi, Sidney Scholl (United States)
42. A Model for Post-Marketing Surveillance of Abuse Liability [179] Edgar H Adams, James A Inciardi, Sidney H Schnoll, Theodore J Cicero, Anne Geller, Alvaro Munoz, Edward C Senay, George E Woody (United States)
43. Costs-Benefits of Resource Utilization in the Quebec Welfare Recipients Population Using Olanzapine or Risperidone [181] Anne-Marie Castilloux, Michelle Savoie, Jacques LeLorier (Canada)
44. The Use of the Number Needed To Harm One Additional Patient (NNH) To Better Understand the Risk of Teratogenic Drugs [183] Danielle Pilon, Anne Pastuszak, Jacques LeLorier (Canada)
45. Upper Gastrointestinal Complications Associated with Use of Non-steroidal Anti-inflammatory Drugs According to the Nature of the Outcome [185] Sonia Hernández-Díaz, Luis A García-Rodríguez (United States, Spain)
46. Efficacy and Cost of HMG-CoA Reductase Inhibitors among Patients with Primary Hyperlipidemia [190] Sylvie Perreault, Jacques Le Lorier (Canada)
47. Using Publicly Available Data To Derive Background Rates When Evaluating Adverse Drug Reaction Reports [194] Lois A La Grenade, Cynthia Kornegay, David J Graham (United States)
48. Steroidal and Non-steroidal Anti-inflammatory Drugs and Risk of Upper Gastrointestinal Bleed/Perforation [197] Sonia Hernández-Díaz, Luis A García-Rodríguez (United States, Spain)
49. Supporting the Safe Use of over-the-Counter Medicines in the UK: A Pilot Pharmacovigilance Study of OTC Ibuprofen [201] Philip C Hannaford, Christine M Bond, Hazel K Sinclair (United Kingdom)
50. Defining Estrogen Exposure in Longitudinal Studies: Impact on Measures of Effect [202] Ilona Csizmadi, Andrea Benedetti, Jean-Paul Collet, James Hanley, Jean-Francois Boivin (Canada)
51. Mortality Risk in People with Impaired Glucose Metabloism in NHANES II Mortality Study According to ADA and WHO Diagnostic Criteria [206] Sharon H Saydah, Montserrat Miret, Jennifer CY Sung, Cristina Varas, Frederick L Brancati (United States, Spain)
52. Pharmacovigilance in Community Pharmacies [208] Teresa Cuchi, Maximo Bartolome (Spain)
53. Meta-Analysis of Adverse Drug Events - The Association between Angiotensin II Receptor Antagonists and Upper Respiratory Tract Infections [213] Toine C Egberts, Albert W Lenderink (The Netherlands)
54. Thyroid Dysfunction and Treatment in an Elderly Urban Population. Data from the Kungsholmen Project [214] Galina Passare, Johan Fastbom, Matti Viitanen, Ove Torring (Sweden)
55. Safety Profile of a Fixed formulation Containing 2.0 mg Estradiol Valerate and 2.0 mg Dienogest for Continuous Combined HRT in Postmenopausal Women [218] Herbert Hoffmann, Thomas Graeser, Bernhard Felsch, Andreas Mueller, Michael Oettel (Germany)
56. Adverse Drug Reaction Monitoring* - the Effect of Aging on Digitoxin Concentration and Overdosing Effects [219] Marion Hippius, Bassam Humaid, Thomas Sicker, Stefan Teweleit, Annemarie Hoffmann (Germany)
57. Tramadol and the Initiation of Anticonvulsant Therapy [223] Michael J Goodman, Jerry H Gurwitz, Arnold Chan, Susan E Andrade, Teri A DeFor, Richard Platt (United States)
58. Factors Associated with Existing and Newly Initiated Antiepileptic Drug Use in Nursing Home Admissions [225] Judith Garrard, Nancy Hardie, Susan Harms, Cynthia Gross, Patricia Bland, Nicole Nitz, Ilo Leppik (United States)
59. Antirheumatic Medication and the Risk for Severe Cutaneous Adverse Reactions (SCAR) [235] Maja Mockenhaupt, Juergen Schlingmann, Jean-Claude Roujeau, Erwin Schoepf (Germany, France)
60. Pindolol-Antidepressants Association. A Meta-Analysis about Early Onset of Action [241] Javier Garcia del Pozo, Alfonso Carvajal, Ana M Rueda de Castro, Ana Alvarez-Requejo (Spain)
61. Anti-Hypertensive Agents and the Risk of Hip or Wrist Fractures in an Otherwise Healthy Community Population [245] Christoph Laer, Jacques LeLorier (Canada)
62. Teratogenic Effects of Antiepileptic Drugs: The Extent and the Impact of Duplicate Publications [253] Alejandro Arana, Lars Bjerrum, Wendy Roberts (Spain, Denmark, United Kingdom)
63. Evaluation of a Safety Signal Generated from Spontaneous Reporting Databases: An Example of a False Positive Signal [255] Isaac W Hammond, Colleen Mockbee, Kenneth Kwong, Edmundo Muniz (United States)
64. Development and Use of a Suicidal Assessment Algorithm for Telephone Interviewers [271] Karen B Pendergast, Suzanne L West, Alicia E Wilson, Ralph W Swindle Jr., Kurt Kroenke (United States)
65. Dose Response Curves with Time Dependant Exposure: The Case of Acetaminophen Gastrointestinal Side Effects [281] Elham Rahme, Dan Pettitt, Jacques LeLorier (Canada, United States)
66. Safety Profile of New Antidepressants [283] Welmoed EE Meijer, Eibert R Heerdink, Lolke Pepplinkhuizen, Jacques ThM van Eijk, Hubert GM Leufkens (The Netherlands)
67. Targets and Treatment of Hypertension in Diabetic Patients [284] Mary J MacLeod, Catherine Cagney (United Kingdom)
68. Calcium Channel Blocker Use and an Increased Risk of Cancer in the Rotterdam Study [287] Annette B Beiderbeck-Noll, Miriam CJM Sturkenboom, Ron MC Herings, Hubert GM Leufkens, Bruno HCh Stricker (The Netherlands)
69. Outcome Guarantees for Drugs in State-Funded Health Services: A Case Study in a United Kingdom Primary Care Group Using Lipid Lowering Drugs [298] Stephen R Chapman, Elly Reeve (United Kingdom)
70. The Canadian Population Constipation Survey: Prevalence of Self-Reported Constipation [305] Grant W Thompson, Jan E Irvine, Pierre Pare, Andrew Eggleston, Laureen Rance, Simon Ferrazzi (Canada)
71. Clinical, Economic and Health Status Outcomes Associated with Antipsychotic Therapy - Results from the Canadian National Outcomes Measurement Study in Schizophrenia [309] Lili Kopala, Richard Williams, Ashok K Malla, Geoff Smith, Mark Atkinson (Canada)
72. Comparison of Pulmonary Toxicity Risks with Antiandrogens [325] Syed R Ahmad, David J Graham, Denise P Toyer, Ronald Wassel, Marianne Mann (United States)
73. Lansoprazole-Associated Hepatotoxicity [327] Syed R Ahmad, David J Graham, Ann Corken (United States)
74. Effect of a Pharmacy-Based Intervention Program on Blood Pressure [329] Isabelle Chabot, Jocelyne Moisan, Jean-Pierre Gregoire, Alain Milot, Monique Richer (Canada)
75. Hepatic Damage Associated with NSAIDs. An Approach from the French and Spanish Pharmacovigilance Databases [330] Jean-Luis Montastruc, Maryse Lapeyre-Mestre, Marie-Pierre Bareille, Alfonso Carvajal, Luis H Martin Arias, Ana M Rueda de Castro (France, Spain)
76. Risk Factors for Significant Adverse Events in the Pain Study [331] Nicholas D Moore, Eric VanGanse, Jean-Marie LePard, Judith K Jones, Richard Wall, Helene Schneid, Francois Verriere (France, United States, United Kingdom, France)
77. Constipation and Health Care Resource Utilization in a Long-Term Care Facility [334] Carol Simms, Geoffrey K Turnbull, Simon Ferrazzi, Laureen Rance (Canada)
78. Identifying Discontinuation of Antihypertensive Medications: Agreement between Patient Reports and Pharmacy Records [342] Michel Gaudet, Jean-Pierre Gregoire, Jocelyne Moisan (Canada)
79. Assessing Appropriateness of Drug Prescribing: Agreement between Data Collected by a Pharmacist and Data Collected by an Archivist [343] Jean-Pierre Gregoire, Isabelle Chabot, Jocelyne Moisan, Michel Gaudet Gaudet (Canada)
80. Tolerability of Antihypertensive Medications in Real Life [349] Jean-Pierre Gregoire, Jocelyne Moisan, Remi Guibert, Antonio Ciampi, Alain Milot, Isabelle Cote, Michel Gaudet (Canada, Australia)
81. Study of Liver Enzyme Monitoring in Patients Receiving Troglitazone [353] David J Graham, Carol R Drinkard, Deborah Shatin (United States)
82. Pramipexole and "Sleep Attacks": A Review of Adverse Events Reported Worldwide [356] Joshua S Benner, Jerry Avorn (United States)
83. Clinical Outcomes in Newly Treated and Untreated Long-Term Care Patients with Symptoms of Depression [358] Judith A Soon, Marc Levine (Canada)
84. Morphine Related Adverse Events in the Elderly and Non-elderly, a Retrospective Cohort Analysis in Ontario, Canada [367] Andrew Eggleston, Nancy Wiesenfeld, Ian Brock, Mike Ingham (Canada)
85. The Shadow Costs of NSAID Therapy: A Population Study [372] Miriam C Sturkenboom, Ferdinando Romano, Giorgio Simon, Maria L Correa Leite, Marco Villa, Alfredo Nicolosi, Giulio Borgnolo, Gabriele Bianchi-Porro, Salvatore Mannino (Italy)
86. Type 2 Diabetes Mellitus. Profile of Newly Diagnosed Patients in Primary Care [385] P Benito, E Faure, R García-Mayor, J S López, J Mesa, L F Pallardo, M Puig-Domingo, R Ravella (Spain)
87. Cardiovascular Risk in a Newly Diagnosed Population of Type 2 Diabetic Patients [395] P Benito, E Faure, R García-Mayor, J S López, J Mesa, L F Pallardo, M Puig-Domingo, R Ravella (Spain)
88. The Prevalence of Drug-Induced Hyponatremia in Elderly [136] JU Rosholm, E Skjelbo, B Himmelstrup, H Nybo, K Kristensen, LF Gram (Denmark)

1. Have We Missed an Opportunity To Improve Patient Care Resulting from Research?: The Designated Peer Review Organization "drPRO" Concept [1] Stanley A Edlavitch, Marvin G Stottlemire, Patricia J Byrns (United States)
2. Pharmacies as Potential Intervention Points: Cisapride and Contraindicated Drugs [3] Judith K Jones, Jeff J Guo, Daniel Fife, Marj Shannon, Suellen Curkendall, Earl Goehring (United States)
3. The Use of Unlicensed and Off-Labeled Medications in a University Medical Center [7] Norberto Krivoy, Michael Leonid (Israel)
4. Evaluating the Potential of an Intervention Aimed at Promoting Oral Rehydration Therapy (ORT) through the Education of Pharmacy Workers [9] Maria de Lourdes Oshiro, Lia Lusitana Cardozo de Castro (Brazil)
5. Utilization Review of Proton Pump Inhibitors [10] Regis Blais, Pierre Madore, Louise Barnard, Nancy Lajeunesse (Canada)
6. Influence of Systemic Chemotherapy on Fertility [19] Maryse Lapeyre-Mestre, Severine Brillouet, Nathalie Caunes, Monique Rigal, Roland Bugat, Jean-Louis Montastruc (France)
7. The Risk of Obstructive Airways Disease in a Glaucoma Population [20] Consuelo Huerta, Luis Alberto Garcia Rodriguez, Christina Strom Moller, Felix M Arellano (Spain, Sweden, United States)
8. Incidence of Ocular Melanoma in the General Population and Glaucoma Patients [21] Consuelo Huerta, Luis Alberto Garcia Rodriguez (Spain)
9. Minocycline-Induced Lupus (MIL) [28] Raymond G Schlienger, Christoph R Meier (Switzerland)
10. Pharmacovigilance of Antihelmintics: A Review of the French Pharmacovigilance Database [37] Elise Simiand-Erdocian, Haleh Bagheri-Charabiani, Jean-Francois Magnaval, Jean-Louis Montastruc (France)
11. Adverse Reactions in Children: A Survey from Spontaneous Reporting in France [39] Maryse Lapeyre-Mestre, Brigitte Hoedt, Jean-Louis Montastruc (France)
12. Side Effects Associated with Postmenopausal Hormone Therapy Discontinuation in a Massachusetts HMO [40] Robert F Reynolds, Carla M Obermeyer, Alexander M Walker, Daniel Guilbert (United States)
13. Risk of Cardiac Adverse Events Associated to Vinorelbine: A Systematic Review of Randomized Clinical Trials [41] Maryse Lapeyre-Mestre, Nicolas Grégoire, Roland Bugat, Jean-Louis Montastruc (France)
14. Initial Therapy of Inflammatory Bowel Disease (IBD) in the United Kingdom [47] James D Lewis, Warren B Bilker, Colleen Brensinger, Brian L Strom (United States)
15. The Adverse Drug Reaction of the Chinese Traditional Herb Medicine [53] Tongtong Wang (China)
16. Drug Interactions with St John's Wort: Case Series from a Spontaneous Reporting Scheme [61] Katharina Hartmann, Silvia Bon, Max Kuhn (Switzerland)
17. Gender Differences in Adverse Drug Reactions [63] Jean-Louis Montastruc, Atoussa Fooladi, Maryse Lapeyre-Mestre, Haleh Bagheri (France)
18. Mortality in Nursing Home Residents with Parkinson's Disease Taking Selegiline [67] Kate L Lapane, Hubert H Fernandez (United States)
19. Randomized Controlled Trial of a Drug Policy Change during Implementation [68] Bruce Carleton, Malcolm Maclure, Shelly Russwurm, Anne M Smith, Colin Dormuth, Lee Boshell, Leanne Warren (Canada)
20. Prevalence of Asthma by Severity in the General Population [71] Heath F Heatlie, Frischer Martin, Clark Wendy (United Kingdom)
21. Use of Expert Panels To Provide Data for Pharmacoeconomic Analyses [74] Rhonda L Bohn, Bruce M Ewenstein, Kathy Putnam, Jerry Avorn (United States)
22. Review of the Types and Timing of Adverse Drug Reactions Cited in "Dear Healthcare Professional" Letters in the United States [75] Kenneth C Kwong, William Brookfield, Man C Fung, Isaac W Hammond, Edmundo Muniz (United States)
23. Employing Retrospective Reviews of Medical Records To Promote Receptiveness to the Implementation of a Hospital Pharmacovigilance Program in Pediatric Inpatient Units [77] Lia Lusitana Cardozo de Castro, Erica Vitorasso, Marcelo Girardi, Maria Gloria Vicente (Brazil)
24. Considering the Clustered Structure of Data in Pharmacoepidemiologic Research [79] Kate L Lapane (United States)
25. Spontaneous Reporting of Adverse Reactions Associated to Antituberculosis Drugs in Spain during the Period 1993-1998 [84] Antonio Blazquez, Myriam Beaulieu, Ramona Mateos (Spain)
26. To What Extent Do Drug Categories Give Information on Actual Drugs Used? [87] C Ineke Neutel, Wikke Walop, Sheril Desjardins-Denault (Canada)
27. A Bayesian Method for the Evaluation of Case Series of Adverse Reactions [88] John A Clark, Stephen L Klincewicz, Norman D LaFrance (United States)
28. Medic-GP - An Example of an Observational, Pharmacoepidemiological Database [91] Justin J Beilby, John E Marley, Don C Walker, Nicole L Chamberlain, Katherine M Duszynski (Australia)
29. Characteristics, Patterns and Trends of Prescription Drug Abuse in Spontaneous Adverse Event Reporting over the Past Three Decades - 1969 to 1998 [93] Jasmanda Hsiao-hui Wu, Man C Fung, Kenneth Kwong, Ken Hornbuckle, Edmundo Muniz (United States)
30. Risk of Severe Skin Disorders in Users of Oral Antifungals [94] Jordi Castellsague, Luis Alberto García Rodríguez, Alberto Duque, Susanne Pérez Gutthann (Spain)
31. Using Prescription Claims Data for Drugs Available over-the-Counter (OTC) [99] Marianne Ulcickas Yood, Kenneth J Rothman, Christine C Johnson, Susan S Jick, Janet Lang, Karen E Wells, Hershel Jick (United States)
32. Repeated Use of Hormonal Emergency Contraception by Younger Women in the UK [103] Sam Rowlands, Hassy Devalia, Ross Lawrenson, John Logie, Bernard Ineichen (United Kingdom)
33. Patterns and Prevalence of Use of Vivelle Ò, Estraderm Ò and Oral Premarin Ò among Women 45 Years of Age and Older in a U.S. Managed Health Care Setting [104] Lia P Gutiérrez (Spain)
34. A Survey of Physician Efficacy Requirements To Change Medical Practice Patterns [105] Mark Oremus, SH Shapiro, JP Collet (Canada)
35. Evaluation of Gender Effect in Adverse Event Reporting Using the FDA Spontaneous Reporting System - A 10-Year Review [106] Jasmanda Hsiao-hui Wu, Man C Fung, Kenneth Kwong, Ken Hornbuckle, Edmundo Muniz (United States)
36. Pain Prevalence in Schoolchildren: A Pilot Survey [109] Conxita Barajas-Diaz, Josep E Banos-Diez, Felix Bosch (Spain)
37. Comparison of Adverse Event Reporting Patterns in Different Age Groups Using the FDA Spontaneous Reporting System - A 10-Year Review [112] Jasmanda Hsiao-hui Wu, Man C Fung, Kenneth Kwong, Ken Hornbuckle, Edmundo Muniz (United States)
38. Safety Profile of the Anti-Cholinergic Tolterodine as Used To Treat Urinary Problems in General Practice in England [128] Nicholas R Dunn, Gillian L Pearce, Saad A Shakir (United Kingdom)
39. Use of Inhaled Corticosteroids in Chronic Pulmonary Disease [129] Lucie Blais, Jean Bourbeau, Odile Sheehy, Jacques LeLorier (Canada)
40. Self-Medication among Portuguese Urban Population [131] Ana Paula Martins, Ana Costa Miranda, Zilda Maria Mendes, Maria Augusta Soares, Ana Patricia Ferreira, Ana Nogueira (Portugal)
41. Evaluation of Published Case Reports' Standards and Notification [135] Colleen M Mockbee, Sara Erbele, Jeffrey Ferguson, Edmundo Muniz (United States)
42. Relative Value Index (RVI) - A Tool for Assessing Value in Non-Dominant Cost-Effective Analyses [137] Mitchell AH Levine, Margaret Woodruff (Canada)
43. Examining Effectiveness of Antibiotic Prescribing and Patient Outcomes Using Episodes of Care [140] Justin J Beilby, John E Marley, Don C Walker, Nicole L Chamberlain, Katherine M Duszynski (Australia)
44. Laxative Prescribing in a South African Patient Setting: A Prescription Database Analysis [142] Ilse Truter (South Africa)
45. EURO-Medicines: An Analysis of the Pharmaceutical Policies in the European Union [143] P Folino-Gallo, T Walley, JC Frolich, A Carvajal, IR Edwards, FP Calamo-Specchia (Italy, United Kingdom, Germany, Spain, Sweden)
46. Montelukast and Improvement of Eczema [144] Pipasha` N Biswas, Lynda V Wilton, Gillian L Pearce, Shayne N Freemantle, Saad AW Shakir (United Kingdom)
47. Incidence and Preventability of Adverse Drug Reactions in a French Medical Emergency Unit [147] Pascale Olivier, Olivier Boulbes, Marie Tubery, Pierre Carles, Jean-Louis Montastruc, Maryse Lapeyre-Mestre (France)
48. Drug Use in Thailand: Problems and Interventions [154] Pathom Sawanpanyalert (Thailand)
49. Patient-Recorded Data in Outcomes Research [155] Eric H Van Ganse, Thierry M Vial, Jacques Descotes (France)
50. Patterns of Prescribing of Hormonal Emergency Contraception by General Practitioners in England and Wales [156] Berhard Ineichen, John W Logie, Sam Rowlands, Ross A Lawrenson (United Kingdom)
51. Medical Resource Utilization for Influenza-Related Complications in a Large US Health Insurance Plan Database [157] Monto S Arnold, Napalkov N Pavel, Wegmuller Yann (United States, Switzerland)
52. An Analysis of over 800 Drug-Induced Life-Threats [166] William N Kelly, Kim Marcelllino (United States)
53. Lyme Vaccine Safety Data Reported to the Vaccine Adverse Event Reporting System (VAERS) of the U.S.A. from the First Year of Use [169] Robert Ball, Miles Braun, Sarah Lathrop, Penina Haber, Gina T Mootrey, Ned Hayes (United States)
54. Evidence Based Information: Is It Dispensed to Pregnant Women by Pharmacists? A Survey in Canada and The Netherlands [187] Suzanne Gerichhausen, Dorothy Lysiewicz, Adrienne Einarson, Gideon Koren (Canada, The Netherlands)
55. Vaccinations against Hepatitis B and Lupus Erythematosus [195] Miriam C Sturkenboom, Bruno Fautrel, Rozenberg Sylvie, Bernard Begaud, Etienne Roullet, Olivier Heinzlef (The Netherlands, France)
56. MEDWATCH Effect - A Pharmaceutical Company Perspective [198] Colleen Mockbee, Kenneth Hornbuckle, Edmundo Muniz (United States)
57. Concentration Impairment during the Prophylactic Use of Mefloquine [203] Melanie M van Riemsdijk, Anne-Marie Ditters, Miriam CJM Sturkenboom, Joke Tulen, Robert Jan Ligthelm, David Overbosch, Ron MC Herings, Bruno HC Stricker (The Netherlands)
58. Pragmatic Trials: Design Features and Implications for Clinical Decision Making [204] Hege F Urdahl, Nick Freemantle (United Kingdom)
59. Measures of Dispropotionality in Spontaneous Reporting Systems of Adverse Drug Reactions: How Do They Relate to Each Other? [207] Eugene P van Puijenbroek, Andrew Bate, Antoine CG Egberts, Marie Lindquist, Hubert GM Leufkens (The Netherlands, Sweden)
60. Estimating "Lag Time" and the "Time to Maximum Effect" in an Ecologic Study of an Intervention [209] Warren B Bilker, Sean Hennessy, Colleen Brensinger, Brian L Strom (United States)
61. E.C.A.M.P. Project: A Population Based Study of Asthma with the Collaboration of Pharmacists and Physicians [211] Maria Grazia Ruccolo, Elisa Sasso, Marilena Romero on behalf of ECAMP group (Italy)
62. The Dutch Cohort of Sildenafil Users: Baseline Characteristics [215] Patrick C Souverein, Antoine CG Egberts, Miriam CJM Sturkenboom, Hubertus GM Leufkens (The Netherlands)
63. Prevalence and Incidence of Diagnosed Allergic Rhinitis in the UK General and Asthmatic Populations [224] Jordi Castellsague, Luís Alberto García Rodríguez (Spain)
64. Development of Case Definitions for Encephalopathy, Encephalitis, and Multiple Sclerosis Reports to the Vaccine Adverse Event Reporting System (VAERS) of the U.S.A. [226] Robert Ball, Neal Halsey, M Miles Braun, Larry Moulton, Arnold Gale, Kottil Rammohan, Max Wiznitzer, Marcel E Salive, the VAERS Working Group (United States)
65. Severe Cutaneous Adverse Reactions (SCAR) after the Use of Anticonvulsive Agents [231] Juergen Schlingmann, Maja Mockenhaupt, Werner Schroeder, Erwin Schlingmann (Germany)
66. Influence of Treatment on Health-Related Quality of Life in a Cohort of COPD Patients [244] Marc Miravitlles, Rafael Vidal, Rosa Lamarca, Jose L Alvarez-Sala, Juan F Masa, Hector Verea, Rafael Zalacaín, Fernando Ros (Spain)
67. The Rate of Failure of Oral Hypoglycaemic Therapy in Type 2 Diabetes: A Population-Based Study [247] PT Donnan, DT Steinke, AD Morris (United Kingdom)
68. Record Linkage To Identify Patients with Coronary Heart Disease. Quality, Benefits and Costs [249] GM Cruickshank, M Duncan, J Foster, F Sullivan, TM MacDonald ()
69. Hyponatremia and Syndrome of Inappropriate Antidiuretic Hormone Reported with the Use of VincristineÒ: An-Over-Representation of Asians [254] Isaac W Hammond, Jeffrey Ferguson, Kenneth Kwong, Edmundo Muniz, Frank Delisle (United States)
70. Descriptive Analyses of the Variation in Medication Costs by RUG Group in US Nursing Homes [259] Kate L Lapane, Vince Mor, Brant Fries, Alan White, Terry Moore (United States)
71. Thalassaemia Major: Geographical Variations in Prevalence, Survival, and Treatment Patterns [260] Alejandro Arana, Suzanne Wait, Margaret Santamas, Alex Ward, Krysta Huybrechts, Tracy Craig, Jaime J Caro, Androulla Eleftheriou (Spain, Switzerland, United States, Cyprus)
72. An Evaluation of Reports of Drug Overdose with CrixivanÒ (Indinavir Sulfate) [266] Heidi P Lehman, Joan O Benson (United States)
73. An On-Line Directory of Database Profiles for Pharmacoepidemiology, Outcomes, and Other Population-Based Research [272] Amishi M Gandhi, Dewei She, Sheryl L Happel Lewis, Deborrah A Gouin, Judith K Jones (United States)
74. Guiding Principles To Compare the Efficacy of Novel Drugs Using RCT Matched Arm Comparisons [280] Christoph Laer, Jacques LeLorier (Canada)
75. Sleep Problems in an Elderly Population: Drug Use and Clinical Correlates [285] Maria Stella T Giron, Yvonne Forsell, Cecilia Bernsten, Mats Thorslund, Johan Fastbom (Sweden)
76. Development of Quality Indicators Based on Medication Use for US Nursing Homes [286] Kate L Lapane, Anne Hume, Norma Owens, David Gifford, Vince Mor (United States)
77. Pill Switches and 'Morning after Effects' [292] Tim J Williams, Corinne S de Vries, Richard DT Farmer (United Kingdom)
78. Evaluating the Safety of Pharmaceuticals in Pregnancy [293] Sheila R Weiss (United States)
79. Hepatitis B Vaccination and Demyelinating Diseases: An Interim Analysis from the Vaccine Safety Datalink [296] Frank DeStefano, Lisa A Jackson, Catherine A Okoro, Robert T Chen (United States)
80. Alendronate, Osteoporotic Fracture, and Gastroduodenal Perforation, Ulcer, or Bleeding [302] James G Donahue, K Arnold Chan, Susan E Andrade, Arne Beck, Myde Boles, Diana S Buist, Vincent J Carey, Julie Chandler, Gary A Chase, Bruce Ettinger, Paul Fishman, Michael J Goodman, Harry A Guess, Jerry H Gurwitz, Andrea Z Lacroix, TR Levin, Richard Platt (United States)
81. Palliative Care in Cancer Patients: An Epidemiological Survey [304] Concetta Spoltore, Atena Civitarese, Franca Goffredo, Rosa Arboretti G, Marilena Romero (Italy)
82. Systemic Mycoses in Critically Ill Patients: Which Study's Approach? [306] Edvige Quitadamo, Catia N Venanzi, Claudio Farina, Marilena Romero (Italy)
83. Web Data Management and Monitoring System for Multicenter Field Studies [308] Jean-Paul Collet, Michel Beland, Ilona Csizmadi, Ann Robinson (Canada)
84. Does Use of Statins and Non-Steroidal Anti-Inflammatory Drugs Spare Bone in Older Men? [310] Donald R Miller, Krall A Elizabeth, Watkins Bradley, West William, Anderson J Jennifer (United States)
85. Prescribing and Outcomes for Elderly Nursing Home Patients with Congestive Heart Failure [314] Judith K Jones, Susan Horn, Randy Smout, Steve Bartels, Mark Monane, Ellen Flaherty, George Taler (United States)
86. Vaccine Risk Perceptions: An Analysis of Calls to a U.S. National Immunization Hotline [315] Sherri Scott, Beth Hibbs, Mary Stuart, Serigne Ndiaye, Bob Chen (United States)
87. Post-Marketing Surveillance for Human Teratogenicity: A Novel Approach [316] Christina D Chambers, Gerald G Briggs, Kenneth L Jones (United States)
88. Pharmacoepidemiology of Antiobesity Drugs in Canada [317] Michiel E Hemels, Ivan Kraljevic, Tom Bigauskas, Marcel Van den Berg, Thomas R Einarson (The Netherlands, Canada)
89. Comparison of Liver Function Test Results among a Population of Osteoarthritis and Rheumatoid Arthritis Patients [323] Mary E Willy, Gurkirpal Singh, Dena R Ramey, David J Graham (United States)
90. Minimum Number of Cases Needed To Estimate Significant Relative Risk in Case-Population Studies [332] Xavier Vidal, Dolors Capellà, Consuelo Pedrós (Spain)
91. Post-Marketing Safety Evaluation of Inactivated Hepatitis a Vaccine (VAQTAÒ, Merck) in 42,110 Adults and Children [341] Ling Su, Steve Black, Henry Shinefield, Edwin Lewis, Paula Ray, Paul M Coplan, Harry A Guess (United States)
92. Confidence Intervals for Risk Evaluation Taking into Account the Uncertainty on the Denominator [352] Pascale Tubert-Bitter, Bernard Begaud, Ghada Miremont (France)
93. Vaccine Adverse Event Reporting System (VAERS), United States, 1991-1999: A 9-Year Experience [189] Penina Haber, Gina J Mootrey, Robert Pless, Robert T Chen (United States)
94. Procedural and Regulatory Differences between the U.S. and the U. K. in Designing and Conducting Pharmacy-Based Actual Use Trials [365] David C Bradford, David L McCammon, Brent C Page, Joseph C Veltri (United States)
95. Modeling Drug Safety Risks and Hazard Rates Using Postmarketing Data [369] David J Graham (United States)
96. Taking a Product over the Counter: Ways To Look at Product Safety in Actual Use [370] Irene Cosmatos, Annette Stemhagen (United States)
97. Variations in Commonly Used Botanical/Herbs in the USA [371] Judith Garrard, Susan L Harms, Amy Matiak (United States)
98. Antibiotics Using and Antibiotic-Resistancy in Regional Burn Center [373] Vera N Ilyina, Alexander N Evstropov (Russia)
99. Age and Gender Differences in Utilization of Asthma Medication in Children and Young Adults in Tayside, Scotland [374] David M McNaughton, Gillian Libby, Peter T Donnan, Thomas M MacDonald (United Kingdom)
100. Interactions between Warfarin and Herbal Remedies - Spontaneous Case Reports on Hypericum Perforatum (St John's Wort) and CurbicinÒ [375] Qun-Ying Yue, Kerstin Jansson (Sweden)
101. The Incidence of Prescribing Potentially Dangerous Drug-Drug Combinations in General (Family) Practice [379] Anthony J Avery, Yen-Fu Chen ()
102. Risk Factors of Hospital Admission in a Cohort of Ambulatory COPD Patients [381] Marc Miravitlles, Cristina Murio, Tina Guerrrero (Spain)
103. Fulfilment of the European Diabetes Policy Group 1999 Criteria in the Cohort of Diabetic Patients from the Midia Study [384] R García-Mayor, P Benito, E Faure, J S López, J Mesa, L F Pallardo, M Puig-Domingo, R Ravella (Spain)
104. Completion Rates of Various Medical Record Abstraction Studies Conducted on Managed Care Populations [389] Heather A Connors, Jon C Clouse (United States)
105. What Is the Impact of Differential Follow-up Time on Studies of Disease Burden in the General Practice Research Database? [390] Susan C Eaton, Lisa J McQuay, Douglas W Clark (United States)
106. The Incidence of Preventable Drug-Related Hospital Admissions [398] Almut G Winterstein, Brian C Sauer, Charles D Hepler (United States)
107. Construgting a Database to Provide a Practical Approach to Determining the Possibility of Serious Adverse Drug Reaction. Preliminary Report [406] Masanori Yoshida, Tetsuo Fujimoto, Mitsuo Umezu, Takeshi Mayama, Yoshiyuki Shimizu, Takashi Shirai, Toshitada Kameda, Ichiro Yano, Junji Kojima, Yuuji Kishi, Shinichi Hanayama (Japan)
108. Ethic Requirements for Pharmacoepidemiological Studies. A Survey to the Spanish Ethic Comittees [407] Josep L Segú, Tina Guerrero, Maite Artés, Joan Juan, Esteve Colomé, Juan S López (Spain)